Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

Share this content:

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

Sponsors and Collaborators
Stanford University
 
Contact
Russell Pachynski
(650) 906-6530
 
Investigators
George Albert Fisher M.D. Ph.D. 
Stanford University
 
Russell Pachynski 
Stanford University  

ClinicalTrials.gov Identifier

NCT01137162

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs